Modern Clinical Trials: Seamless Designs and Master Protocols

Area of Science:

• Oncology
• Clinical Trial Design
• Drug Development

Background:

• Drug development is lengthy and costly, especially for cancer Phase II/III trials, leading to high failure rates.
• Challenges in cancer drug development necessitate streamlined approaches.
• Seamless clinical trials and master protocols offer solutions to improve efficiency.

Purpose of the Study:

• To explore the advantages of seamless clinical trials and master protocols.
• To highlight principles contributing to the success of these innovative trial designs.
• To acknowledge regulatory considerations and challenges associated with these methods.

Main Methods:

• Seamless clinical trials allow for fluid transitions between trial phases, accelerating promising therapy development.
• Master protocols provide a structured framework for investigating multiple treatments and patient subgroups within a single trial.
• Real-world trial examples are used to illustrate the application and benefits of these methodologies.

Main Results:

• Discussion of advantages through real trial examples.
• Identification of key principles for successful implementation.
• Acknowledgement of regulatory aspects and potential hurdles.

Conclusions:

• Seamless designs and master protocols can significantly enhance confirmatory clinical trials.
• These innovative approaches hold the potential to expedite patient access to life-saving cancer treatments.
• Improved efficiency in cancer drug development is a key outcome.